JYHB2400459 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2024-08-20 | | | | | view |
JYHZ2400073 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | License Renew | 2024-03-26 | | | | | view |
JTH2400035 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs | Disposable Import Drug Application | 2024-03-04 | | | | | view |
JYHB2400111 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2024-03-02 | | | | | view |
JYHB2300730 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2023-12-19 | | | | | view |
JYHB2300304 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2023-05-24 | | | | | view |
JYHB2200313 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2022-06-21 | | | | | view |
JYHB2002759 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2021-01-05 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-01-04 | view |
JXHL2000354 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Import Drug Application | 2021-01-05 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-01-04 | view |
JXHL2000355 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Import Drug Application | 2021-01-05 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-01-04 | view |
JYHB2001496 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2020-08-20 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Filed | 2020-08-31 | view |
JYHB2000236 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs | Supplementary Application | 2020-03-21 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2020-06-19 | view |
JXHS1800025 | 糠酸氟替卡松乌美溴铵维兰特罗吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Import Drug Application | 2018-06-28 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2019-11-08 | view |
JXHL1400135 | 糠酸氟替卡松/溴化Umeclidinium/三苯乙酸维兰特罗(GW685698/ GSK573719/ GW642444)吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs | Import Drug Application | 2014-04-23 | Glaxo Group Limited. | Glaxo Group Ltd | Certificate Issued | 2015-05-28 | view |
JXHL1400053 | 糠酸氟替卡松/溴化Umeclidinium/三苯乙酸维兰特罗(GW685698/ GSK573719/ GW642444)吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs | Import Drug Application | 2014-02-26 | Glaxo Group Limited. | Glaxo Group Ltd | Certificate Issued | 2015-05-28 | view |
JXHL1300223 | GSK573719 | umeclidinium bromide | Other | Chemical Drugs | Import Drug Application | 2013-08-02 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2015-02-12 | view |
JXHL1200024 | GSK573719/GW642444 | umeclidinium bromide;vilanterol | Other | Chemical Drugs | Import Drug Application | 2012-02-09 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2012-06-14 | view |
JXHL1100183 | GSK573719/GW642444 | umeclidinium bromide;vilanterol | Other | Chemical Drugs | Import Drug Application | 2011-06-09 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2012-03-15 | view |